Does PALBOCICLIB ISETHIONATE Cause Malignant neoplasm progression? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Malignant neoplasm progression have been filed in association with PALBOCICLIB ISETHIONATE. This represents 22.0% of all adverse event reports for PALBOCICLIB ISETHIONATE.
11
Reports of Malignant neoplasm progression with PALBOCICLIB ISETHIONATE
22.0%
of all PALBOCICLIB ISETHIONATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PALBOCICLIB ISETHIONATE?
Of the 11 reports.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB ISETHIONATE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB ISETHIONATE Cause?
Neutropenia (19)
Cytopenia (9)
Hepatitis (9)
Diarrhoea (6)
Metastases to bone (6)
Breast cancer metastatic (5)
Metastases to liver (5)
Syncope (5)
White blood cell count decreased (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)